clinical trials

Partner Content

Real-world-evidence-rare-disease-pharmaphorum

Partner Content

Real-world evidence: breaking boundaries in rare disease

The COVID-19 pandemic has added a new layer of complexity to the drug development process.

Views & Analysis

Unlocking the potential in rare disease research with decent...

A survey by rare disease patient network Raremark found that 86% of the community members asked were interested in taking part in clinical trials.

Views & Analysis

A collaborative approach to greater diversity in clinical tr...

The need for diversity in clinical trial populations has been a topic of discussion across regulators and the industry in general for decades.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Webinars

Coordinating and delivering research in the pandemic: The UK...

The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical research at a time of immense pressure and stress on personnel and resou

News

Bioclinica boosts digital trial credentials with Saliency bu...

With the ink barely dry on its last merger agreement, clinical trial and imaging specialist Bioclinica is on an expansive drive once again, buying digital clinical trial specialist Saliency

Views & Analysis